Uni-Bio Science Group Limited (0690.HK)
HKD 0.07
(0.0%)
HKD 0.07
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 325.05 Million HKD | 12.33% |
| 2022 | 292.63 Million HKD | -1.86% |
| 2021 | 298.19 Million HKD | 28.26% |
| 2020 | 232.49 Million HKD | -6.06% |
| 2019 | 247.48 Million HKD | 3.46% |
| 2018 | 239.2 Million HKD | 11.86% |
| 2017 | 213.83 Million HKD | 17.22% |
| 2016 | 182.41 Million HKD | 11.83% |
| 2015 | 163.12 Million HKD | 0.17% |
| 2014 | 162.84 Million HKD | 8.05% |
| 2013 | 150.7 Million HKD | 16.6% |
| 2012 | 129.24 Million HKD | 13.57% |
| 2011 | 113.8 Million HKD | -1.37% |
| 2010 | 115.38 Million HKD | -54.58% |
| 2009 | 254.05 Million HKD | -41.49% |
| 2008 | 434.23 Million HKD | 115.48% |
| 2007 | 201.52 Million HKD | 237.8% |
| 2006 | 59.65 Million HKD | 0.47% |
| 2005 | 59.37 Million HKD | 123.95% |
| 2004 | 26.51 Million HKD | -19.53% |
| 2003 | 32.94 Million HKD | -9.42% |
| 2002 | 36.37 Million HKD | 105.55% |
| 2001 | 17.69 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 79.39 Million HKD | 0.0% |
| 2024 Q1 | 79.39 Million HKD | -50.75% |
| 2023 FY | 328.72 Million HKD | 12.33% |
| 2023 Q1 | 77.51 Million HKD | -51.36% |
| 2023 Q2 | 160.67 Million HKD | 107.27% |
| 2023 Q3 | 81.22 Million HKD | -49.45% |
| 2023 Q4 | 161.19 Million HKD | 98.46% |
| 2022 Q4 | 159.37 Million HKD | 94.99% |
| 2022 Q1 | 64.52 Million HKD | -60.17% |
| 2022 Q2 | 130.51 Million HKD | 102.27% |
| 2022 Q3 | 81.73 Million HKD | -37.38% |
| 2022 FY | 292.63 Million HKD | -1.86% |
| 2021 Q4 | 162.01 Million HKD | 84.39% |
| 2021 Q1 | 60.64 Million HKD | -60.6% |
| 2021 Q2 | 119.31 Million HKD | 96.75% |
| 2021 Q3 | 87.86 Million HKD | -26.36% |
| 2021 FY | 298.19 Million HKD | 28.26% |
| 2020 Q2 | 68.38 Million HKD | 100.86% |
| 2020 FY | 232.49 Million HKD | -6.06% |
| 2020 Q4 | 153.91 Million HKD | 66.97% |
| 2020 Q3 | 92.18 Million HKD | 34.79% |
| 2020 Q1 | 34.04 Million HKD | -73.96% |
| 2019 Q3 | 70.79 Million HKD | -39.33% |
| 2019 Q2 | 116.69 Million HKD | 569.65% |
| 2019 Q1 | 17.42 Million HKD | -75.46% |
| 2019 FY | 247.48 Million HKD | 3.46% |
| 2019 Q4 | 130.76 Million HKD | 84.71% |
| 2018 FY | 239.2 Million HKD | 11.86% |
| 2018 Q1 | 57.42 Million HKD | -64.84% |
| 2018 Q3 | 71 Million HKD | 23.66% |
| 2018 Q2 | 57.42 Million HKD | 0.0% |
| 2018 Q4 | 71 Million HKD | 0.0% |
| 2017 Q2 | 42.93 Million HKD | 0.0% |
| 2017 Q1 | 42.93 Million HKD | -10.54% |
| 2017 FY | 213.83 Million HKD | 17.22% |
| 2017 Q4 | 163.31 Million HKD | 0.0% |
| 2017 Q3 | 163.31 Million HKD | 280.41% |
| 2016 Q4 | 47.99 Million HKD | 0.0% |
| 2016 Q1 | 41.28 Million HKD | -3.62% |
| 2016 FY | 182.41 Million HKD | 11.83% |
| 2016 Q3 | 47.99 Million HKD | 16.23% |
| 2016 Q2 | 41.28 Million HKD | 0.0% |
| 2015 Q3 | 42.84 Million HKD | 10.91% |
| 2015 Q4 | 42.84 Million HKD | 0.0% |
| 2015 FY | 163.12 Million HKD | 0.17% |
| 2015 Q1 | 38.62 Million HKD | 0.0% |
| 2015 Q2 | 38.62 Million HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 FY | 162.84 Million HKD | 8.05% |
| 2014 Q1 | 192.74 Million HKD | 0.0% |
| 2013 FY | 150.7 Million HKD | 16.6% |
| 2013 Q4 | 192.74 Million HKD | 534.3% |
| 2013 Q3 | 30.38 Million HKD | 0.0% |
| 2013 Q2 | 30.38 Million HKD | -20.49% |
| 2013 Q1 | 38.21 Million HKD | 0.0% |
| 2012 Q1 | 25.57 Million HKD | 0.0% |
| 2012 FY | 129.24 Million HKD | 13.57% |
| 2012 Q4 | 38.21 Million HKD | 51.05% |
| 2012 Q3 | 25.3 Million HKD | 0.0% |
| 2012 Q2 | 25.3 Million HKD | -1.08% |
| 2011 FY | 113.8 Million HKD | -1.37% |
| 2011 Q4 | 25.57 Million HKD | 0.0% |
| 2010 FY | 115.38 Million HKD | -54.58% |
| 2009 FY | 254.05 Million HKD | -41.49% |
| 2008 FY | 434.23 Million HKD | 115.48% |
| 2007 FY | 201.52 Million HKD | 237.8% |
| 2006 FY | 59.65 Million HKD | 0.47% |
| 2005 FY | 59.37 Million HKD | 123.95% |
| 2004 FY | 26.51 Million HKD | -19.53% |
| 2003 FY | 32.94 Million HKD | -9.42% |
| 2002 FY | 36.37 Million HKD | 105.55% |
| 2001 FY | 17.69 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 739.25 Million HKD | 56.03% |